摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,3,5,5-tetramethylcyclohex-1-enyl trifluoromethanesulfonate | 86544-77-6

中文名称
——
中文别名
——
英文名称
3,3,5,5-tetramethylcyclohex-1-enyl trifluoromethanesulfonate
英文别名
3,3,5,5-tetramethylcyclohex-1-en-1-yl triflate;trifluoro-methanesulfonic acid 3,3,5,5-tetramethyl-cyclohex-1-enyl ester;trifluoromethanesulfonic acid 3,3,5,5-tetramethylcyclohex-1-enyl ester;3,3,5,5-tetramethyl-cyclohex-1-en-1-yl trifluoromethanesulfonate;(3,3,5,5-tetramethylcyclohexen-1-yl) trifluoromethanesulfonate
3,3,5,5-tetramethylcyclohex-1-enyl trifluoromethanesulfonate化学式
CAS
86544-77-6
化学式
C11H17F3O3S
mdl
——
分子量
286.315
InChiKey
UOWYGHLQKCPXDU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    277.6±40.0 °C(Predicted)
  • 密度:
    1.25±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.5
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.82
  • 拓扑面积:
    51.8
  • 氢给体数:
    0
  • 氢受体数:
    6

SDS

SDS:cf9f2315f66340e045fa55d8f1bd9ee2
查看

上下游信息

反应信息

  • 作为反应物:
    描述:
    3,3,5,5-tetramethylcyclohex-1-enyl trifluoromethanesulfonate 在 palladium diacetate 1,1'-双(二苯基膦)二茂铁甲酸四丁基氯化铵三乙胺sodium t-butanolate 作用下, 以 甲苯 为溶剂, 反应 21.0h, 生成 C24H32O
    参考文献:
    名称:
    4-Aryl- and 4-Vinyl-2,2-Dialkyl-3-chromenes from Tertiary 3-(o-Bromophenyl)propynols via a Palladium-Catalyzed Hydroarylation/Hydrovinylation-Cyclization Sequence
    摘要:
    通过一步法,由叔3-(邻溴苯基)炔丙醇和芳基碘或乙烯基三氟甲磺酸酯制备了4-芳基和4-乙烯基-2,2-二烷基-3-色满。该过程包括在通过氢芳基化或氢乙烯基化步骤[Pd(OAc)2、Et3N、HCOOH、Bu4NCl、甲苯]得到的粗混合物中加入t-BuONa、dppf以及适当的新鲜Pd(OAc)2。一般来说,4-芳基和4-乙烯基-2,2-二烷基-3-色满可以高区域选择性获得,总产率从满意到高。乙烯基三氟甲磺酸酯倾向于比芳基碘提供更高的产率。
    DOI:
    10.1055/s-2006-939048
  • 作为产物:
    参考文献:
    名称:
    1,2-Di(cyclic)substituted benzene compounds
    摘要:
    在一个方面,本发明提供具有式(1)或(100)的化合物,其盐或前述的水合物,这些化合物表现出优异的细胞粘附抑制作用或细胞浸润抑制作用,并且可用作治疗或预防与白细胞粘附和浸润相关的各种炎症性疾病和自身免疫疾病的药物,例如炎症性肠病(尤其是溃疡性结肠炎或克罗恩病)、肠易激综合征;类风湿性关节炎、牛皮癣、多发性硬化、哮喘和特应性皮炎。 其中R10代表可选择地取代的环烷基等,R20-23代表氢、烷基、烷氧基等,R30-32代表氢、烷基、氧代基等,R40代表可选择地取代的烷基等。
    公开号:
    US20050261291A1
点击查看最新优质反应信息

文献信息

  • <b>Preparation of Indoles from </b> <b><i>o</i></b> <b>-Alkynyltrifluoroacetanilides Through the Aminopalladation­-Reductive Elimination Process</b>
    作者:Sandro Cacchi、Giancarlo Fabrizi、Luca Parisi
    DOI:10.1055/s-2004-815993
    日期:——
    The functionalized pyrrole nucleus contained in the indole system has been assembled via the palladium-catalyzed reaction of o-alkynyltrifluoroacetanilides with organic halides/triflates or allyl carbonates. In the presence of carbon monoxide, a three-component reaction can take place and indole derivatives incorporating a molecule of carbon monoxide have been obtained.
    吲哚体系中所含的官能化吡咯核通过邻炔基三氟乙酰苯胺与有机卤化物/三氟甲磺酸酯或碳酸烯丙酯的钯催化反应组装而成。在一氧化碳存在的情况下,可以发生三组分反应,并获得掺入一氧化碳分子的吲哚衍生物。
  • 1,2-Di(cyclic)substituted benzene compounds
    申请人:Kawahara Tetsuya
    公开号:US20050261291A1
    公开(公告)日:2005-11-24
    In one aspect, the present invention provides compounds having formula (1) or (100), a salt thereof or a hydrate of the foregoing, which compounds exhibit excellent cell adhesion inhibitory action or cell infiltration inhibitory action, and are useful as therapeutic or prophylactic agents for various inflammatory diseases and autoimmune diseases associated with adhesion and infiltration of leukocytes, such as inflammatory bowel disease (particularly ulcerative colitis or Crohn's disease), irritable bowel syndrome; rheumatoid arthritis, psoriasis, multiple sclerosis, asthma and atopic dermatitis. wherein R10 represents optionally substituted cycloalkyl, etc., R20-23 represent hydrogen, alkyl, alkoxy, etc., R30-32 represent hydrogen, alkyl, oxo, etc., and R40 represents optionally substituted alkyl, etc.
    在一个方面,本发明提供具有式(1)或(100)的化合物,其盐或前述的水合物,这些化合物表现出优异的细胞粘附抑制作用或细胞浸润抑制作用,并且可用作治疗或预防与白细胞粘附和浸润相关的各种炎症性疾病和自身免疫疾病的药物,例如炎症性肠病(尤其是溃疡性结肠炎或克罗恩病)、肠易激综合征;类风湿性关节炎、牛皮癣、多发性硬化、哮喘和特应性皮炎。 其中R10代表可选择地取代的环烷基等,R20-23代表氢、烷基、烷氧基等,R30-32代表氢、烷基、氧代基等,R40代表可选择地取代的烷基等。
  • The palladium-catalysed vinylic substitution of vinyl triflates with β-substituted-α,β-unsaturated carbonyl compounds. An application to the synthesis of cardenolides
    作者:Antonio Arcadi、Sandro Cacchi、Giancarlo Fabrizi、Fabio Marinelli、Paola Pace
    DOI:10.1016/0040-4020(96)00303-1
    日期:1996.5
    Vinyl triflates react with β-substituted-α,β-unsaturated aldehydes, ketones, and esters in the presence of catalytic amounts of Pd(OAc)2 and an exeess of KOAc, omitting phosphine ligands, to give vinylic substitution products in good to high yield with high regioselectivity. The added vinyl unit is preferentially linked to the β-carbon atom. As to the stereochemistry, vinylic substitution products
    在催化量的Pd(OAc)2和KOAc的存在下,乙烯基三氟甲磺酸酯与β-取代的α,β-不饱和醛,酮和酯反应,省去了膦配体,从而得到了高至高的乙烯基取代产物具有高区域选择性的收率。添加的乙烯基单元优先连接至β-碳原子。关于立体化学,乙烯基取代产物在预先存在的β-取代基的同一侧上含有羰基。事实证明,使用KOAc不仅优于叔胺,而且在添加或不添加盐(例如LiCl和n -Bu 4)的情况下均优于碳酸或碳酸氢盐碱。NCl。报道了该反应在腰果内酯衍生物的合成中的应用。根据β-取代的α,β-不饱和羰基化合物的性质,该反应可产生氢乙烯基化(正式的共轭加成)产物。
  • SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF
    申请人:CAO Bin
    公开号:US20100075994A1
    公开(公告)日:2010-03-25
    The present invention relates to a series of substituted dihydro and tetrahydro oxazolopyrimidinones, specifically, to a series of 2-substituted-2,3-dihydro-oxazolo[3,2-a]pyrimidin-7-ones and 2-substituted-2,3,5,6-tetra-hydro-oxazolo[3,2-a]pyrimidin-7-ones of formula (I): Wherein p, n, X, Y, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 are as defined herein. This invention also relates to methods of making these compounds including novel intermediates. The compounds of this invention are modulators of metabotropic glutamate receptors (mGluR), particularly, mGluR2 receptor. Therefore, the compounds of this invention are useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of central nervous system disorders (CNS), including but not limited to acute and chronic neurodegenerative conditions, psychoses, convulsions, anxiety, depression, migraine, pain, sleep disorders and emesis.
    本发明涉及一系列取代二氢和四氢噁唑嘧啶酮,具体地说,涉及一系列式(I)的2-取代-2,3-二氢-噁唑并[3,2-a]嘧啶-7-酮和2-取代-2,3,5,6-四氢-噁唑并[3,2-a]嘧啶-7-酮: 其中p、n、X、Y、R1、R2、R3、R4、R5、R6、R7和R8如本文所定义。本发明还涉及制备这些化合物的方法,包括新颖的中间体。本发明的化合物是代谢型谷氨酸受体(mGluR)的调节剂,特别是mGluR2受体。因此,本发明的化合物在药物制剂中具有用途,特别是在治疗和/或预防各种中枢神经系统疾病(CNS)方面,包括但不限于急性和慢性神经退行性疾病、精神病、癫痫、焦虑、抑郁、偏头痛、疼痛、睡眠障碍和呕吐。
  • A method for the regiospecific synthesis of enol triflates by enolate trapping
    作者:John E. Mc Murry、William J. Scott
    DOI:10.1016/s0040-4039(00)81581-6
    日期:1983.1
    Enol triflates can be prepared in high yield from regiospecifically generated enolates by trapping with N-phenyltrifluoromethanesulfonimide.
    通过用N-苯基三氟甲烷磺酰亚胺捕获,可以由区域特异性生成的烯醇酸酯高产率地制备烯醇三氟甲磺酸酯。
查看更多